169 related articles for article (PubMed ID: 25437644)
1. Exogenous C-type natriuretic peptide infusion ameliorates unilateral ureteral obstruction-induced tubulointerstitial fibrosis in rats.
Hu P; Zhang XC; Kong HB; Xia X; Hu B; Qin YH
Lab Invest; 2015 Mar; 95(3):263-72. PubMed ID: 25437644
[TBL] [Abstract][Full Text] [Related]
2. Overexpressed C-type natriuretic peptide serves as an early compensatory response to counteract extracellular matrix remodeling in unilateral ureteral obstruction rats.
Hu P; Wang J; Zhao XQ; Hu B; Lu L; Qin YH
Mol Biol Rep; 2013 Feb; 40(2):1429-41. PubMed ID: 23073778
[TBL] [Abstract][Full Text] [Related]
3. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
4. Fluorofenidone attenuates renal interstitial fibrosis in the rat model of obstructive nephropathy.
Li BX; Tang YT; Wang W; Xie YY; Wang NS; Yuan QJ; Zhang FF; Peng ZZ; Hu GY; Tao LJ
Mol Cell Biochem; 2011 Aug; 354(1-2):263-73. PubMed ID: 21594754
[TBL] [Abstract][Full Text] [Related]
5. Increased urinary C-type natriuretic peptide excretion may be an early marker of renal tubulointerstitial fibrosis.
Hu P; Wang J; Hu B; Lu L; Xuan Q; Qin YH
Peptides; 2012 Sep; 37(1):98-105. PubMed ID: 22743139
[TBL] [Abstract][Full Text] [Related]
6. Endogenous relaxin is a naturally occurring modulator of experimental renal tubulointerstitial fibrosis.
Hewitson TD; Mookerjee I; Masterson R; Zhao C; Tregear GW; Becker GJ; Samuel CS
Endocrinology; 2007 Feb; 148(2):660-9. PubMed ID: 17095590
[TBL] [Abstract][Full Text] [Related]
7. [Experimental study on effect of matrine in alleviating renal tubulointerstitial fibrosis in unilateral ureteral obstruction model].
Fu P; Feng M; Zhang Z
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2006 Feb; 26(2):140-3. PubMed ID: 16548356
[TBL] [Abstract][Full Text] [Related]
8. C-type natriuretic peptide suppresses mesangial proliferation and matrix expression via a MMPs/TIMPs-independent pathway in vitro.
Huang BY; Hu P; Zhang DD; Jiang GM; Liu SY; Xu Y; Wu YF; Xia X; Wang Y
J Recept Signal Transduct Res; 2017 Aug; 37(4):355-364. PubMed ID: 28554303
[TBL] [Abstract][Full Text] [Related]
9. [The expression of AT1A receptor and its modulation by benazepril in the renal tubulointerstitial lesions induced by ureteral obstruction].
Chen X; Shi S; Li W
Zhonghua Yi Xue Za Zhi; 1997 Apr; 77(4):245-8. PubMed ID: 9596920
[TBL] [Abstract][Full Text] [Related]
10. Paradoxical expressions of natriuretic peptide receptor-C and neutral endopeptidase account for C-type natriuretic peptide decline during the progression of experimental obstructive nephropathy.
Hu P; Zhao XQ; Wang J; Kong HB; Hu B; Lu L; Qin YH
J Renin Angiotensin Aldosterone Syst; 2014 Dec; 15(4):458-65. PubMed ID: 24189506
[TBL] [Abstract][Full Text] [Related]
11. Neutral endopeptidase and natriuretic peptide receptors participate in the regulation of C-type natriuretic peptide expression in renal interstitial fibrosis.
Hu P; Xia X; Xuan Q; Huang BY; Liu SY; Zhang DD; Jiang GM; Xu Y; Qin YH
J Recept Signal Transduct Res; 2017 Feb; 37(1):71-83. PubMed ID: 27278005
[TBL] [Abstract][Full Text] [Related]
12. Nitric oxide generation ameliorates the tubulointerstitial fibrosis of obstructive nephropathy.
Morrissey JJ; Ishidoya S; McCracken R; Klahr S
J Am Soc Nephrol; 1996 Oct; 7(10):2202-12. PubMed ID: 8915981
[TBL] [Abstract][Full Text] [Related]
13. TIMP-1 deficiency does not attenuate interstitial fibrosis in obstructive nephropathy.
Kim H; Oda T; López-Guisa J; Wing D; Edwards DR; Soloway PD; Eddy AA
J Am Soc Nephrol; 2001 Apr; 12(4):736-748. PubMed ID: 11274235
[TBL] [Abstract][Full Text] [Related]
14. [A Study on the Role and Mechanism of Fenofibrate in Mice Renal Fibrosis Induced by Unilateral Ureteral Obstruction].
Xu SS; Li S; Zhang XX; Qi JZ; Li GY
Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 Sep; 51(5):670-674. PubMed ID: 32975082
[TBL] [Abstract][Full Text] [Related]
15. Transforming growth factor-beta-dependent and -independent pathways of induction of tubulointerstitial fibrosis in beta6(-/-) mice.
Ma LJ; Yang H; Gaspert A; Carlesso G; Barty MM; Davidson JM; Sheppard D; Fogo AB
Am J Pathol; 2003 Oct; 163(4):1261-73. PubMed ID: 14507636
[TBL] [Abstract][Full Text] [Related]
16. TIMP-1 gene expression and PAI-1 antigen after unilateral ureteral obstruction in the adult male rat.
Duymelinck C; Dauwe SE; De Greef KE; Ysebaert DK; Verpooten GA; De Broe ME
Kidney Int; 2000 Sep; 58(3):1186-201. PubMed ID: 10972681
[TBL] [Abstract][Full Text] [Related]
17. [Change in plasma H2S level and therapeutic effect of H2S supplementation in tubulointerstitial fibrosis among rats with unilateral ureteral obstruction].
Zhao DA; Liu J; Huang Q; Han ZM
Zhongguo Dang Dai Er Ke Za Zhi; 2013 Oct; 15(10):903-8. PubMed ID: 24131846
[TBL] [Abstract][Full Text] [Related]
18. Unilateral ureteral obstruction causes gut microbial dysbiosis and metabolome disorders contributing to tubulointerstitial fibrosis.
Chen L; Chen DQ; Liu JR; Zhang J; Vaziri ND; Zhuang S; Chen H; Feng YL; Guo Y; Zhao YY
Exp Mol Med; 2019 Mar; 51(3):1-18. PubMed ID: 30918245
[TBL] [Abstract][Full Text] [Related]
19. Brilliant blue G, a P2X7 receptor antagonist, attenuates early phase of renal inflammation, interstitial fibrosis and is associated with renal cell proliferation in ureteral obstruction in rats.
Pereira JMS; Barreira AL; Gomes CR; Ornellas FM; Ornellas DS; Miranda LC; Cardoso LR; Coutinho-Silva R; Schanaider A; Morales MM; Leite M; Takiya CM
BMC Nephrol; 2020 May; 21(1):206. PubMed ID: 32471386
[TBL] [Abstract][Full Text] [Related]
20. Rapamycin reduces renal hypoxia, interstitial inflammation and fibrosis in a rat model of unilateral ureteral obstruction.
Liu CF; Liu H; Fang Y; Jiang SH; Zhu JM; Ding XQ
Clin Invest Med; 2014 Jun; 37(3):E142. PubMed ID: 24895989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
